1 h 3 min
Seminar, Hosted by World Stroke Organization — World Stroke Academy Webinars
Factor XI/XIa Inhibitors for Stroke Prevention: Evolving Evidence and Clinical Relevance
John Eikelboom, Ashkan Shoamanesh and Gisele Sampaio Silva
McMaster University, Canada; McMaster University; Population Health Research Institute (PHRI), Canada; Federal University of São Paulo; Albert Einstein Hospital, Brazil
Recording
Abstract
An in-depth review of the emerging evidence on factor XI and factor XIa inhibitors for stroke prevention, their clinical implications and the likely future directions for antithrombotic therapy. John Eikelboom explains the mechanism of action of factor XI/XIa inhibitors and their role in preventing stroke; Ashkan Shoamanesh presents recent clinical-trial findings on their safety and efficacy; and Gisele Sampaio Silva considers how these agents may change current antithrombotic treatment strategies in stroke prevention.
Topics
- factor XIa inhibitors, search World Wide
- stroke prevention, broader topic: prevention
- antithrombotic therapy, broader topic: therapy
- factor XI, search World Wide
- factor XIa, search World Wide
- Factor XI/XIa Inhibitors, search World Wide
- mechanism of action, search World Wide
- safety
- efficacy
- treatment strategies